{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:51:37Z","timestamp":1792759897230,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["20\/317"],"award-info":[{"award-number":["20\/317"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001537","name":"University of Auckland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009317","name":"Faculty of Health and Medical Sciences, University of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020419","name":"Buchanan Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020419","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.xphs.2024.06.011","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T23:09:54Z","timestamp":1718665794000},"page":"2756-2763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Mechanism of Ocular Penetration of Lipophilic Drugs from Lipophilic Vehicles"],"prefix":"10.1016","volume":"113","author":[{"given":"Carmen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9366-4882","authenticated-orcid":false,"given":"Jack Jonathan","family":"Maran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5997-5994","authenticated-orcid":false,"given":"Ilva D.","family":"Rupenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3831-3833","authenticated-orcid":false,"given":"Priyanka","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.xphs.2024.06.011_bib0001","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/jps.21200","article-title":"Molecular Design for Enhancement of Ocular Penetration","volume":"97","author":"Shirasaki","year":"2008","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"5","key":"10.1016\/j.xphs.2024.06.011_bib0002","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s11095-010-0292-6","article-title":"The rule of five for non-oral routes of drug delivery: ophthalmic, inhalation and transdermal","volume":"28","author":"Choy","year":"2011","journal-title":"Pharmaceutical research"},{"issue":"1","key":"10.1016\/j.xphs.2024.06.011_bib0003","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/jop.2021.0069","article-title":"Eyes on Lipinski's Rule of Five: A New \u201cRule of Thumb\u201d for Physicochemical Design Space of Ophthalmic Drugs","volume":"38","author":"Karami","year":"2022","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"4","key":"10.1016\/j.xphs.2024.06.011_bib0004","first-page":"1032","article-title":"A Novel Method to Evaluate Residence Time in Humans Using a Nonpenetrating Fluorescent Tracer","volume":"43","author":"Meadows","year":"2002","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"8","key":"10.1016\/j.xphs.2024.06.011_bib0005","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/OPX.0b013e3181824de3","article-title":"Precorneal Residence Time of Artificial Tears Measured in Dry Eye Subjects","volume":"85","author":"Paugh","year":"2008","journal-title":"Optometry and Vision Science"},{"issue":"1","key":"10.1016\/j.xphs.2024.06.011_bib0006","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0169-409X(95)00010-5","article-title":"Ocular absorption following topical delivery","volume":"16","author":"J\u00e4rvinen","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.xphs.2024.06.011_bib0007","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1007\/s11095-010-0132-8","article-title":"Prediction of the corneal permeability of drug-like compounds","volume":"27","author":"Kidron","year":"2010","journal-title":"Pharmaceutical research"},{"issue":"11","key":"10.1016\/j.xphs.2024.06.011_bib0008","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/jps.2600721108","article-title":"Corneal penetration behavior of beta-blocking agents II: Assessment of barrier contributions","volume":"72","author":"Huang","year":"1983","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2024.06.011_bib0009","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: The good, the bad and the ugly","volume":"29","author":"Baudouin","year":"2010","journal-title":"Progress in Retinal and Eye Research"},{"issue":"3","key":"10.1016\/j.xphs.2024.06.011_bib0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1367-0484(98)80026-X","article-title":"Disruption of the tear film by the application of small drops of saline and surfactant","volume":"21","author":"Cho","year":"1998","journal-title":"Contact Lens and Anterior Eye"},{"issue":"1","key":"10.1016\/j.xphs.2024.06.011_bib0011","first-page":"40","article-title":"EyeSol: a Novel Topical Ocular Drug Delivery System for Poorly Soluble Drugs","volume":"13","author":"Scherer","year":"2013","journal-title":"Drug Development and Delivery"},{"issue":"2","key":"10.1016\/j.xphs.2024.06.011_bib0012","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/pharmaceutics13020207","article-title":"Formulation Considerations for the Management of Dry Eye Disease","volume":"13","author":"Agarwal","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.xphs.2024.06.011_bib0013","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2018.01.019","article-title":"Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs","volume":"538","author":"Agarwal","year":"2018","journal-title":"International Journal of Pharmaceutics"},{"issue":"5","key":"10.1016\/j.xphs.2024.06.011_bib0014","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1208\/s12249-021-02050-6","article-title":"Ocular Distribution of Papaverine Using Non-aqueous Vehicles","volume":"22","author":"Agarwal","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2024.06.011_bib0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejpb.2023.05.005","article-title":"Preclinical characterization of water-free cyclosporine eye drops \u2013 Factors impacting ocular penetration ex vivo and in vivo","volume":"188","author":"Agarwal","year":"2023","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.xphs.2024.06.011_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114867","article-title":"Non-aqueous formulations in topical ocular drug delivery \u2013 A paradigm shift?","volume":"198","author":"Agarwal","year":"2023","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"11","key":"10.1016\/j.xphs.2024.06.011_bib0017","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.idairyj.2006.06.015","article-title":"Medium-chain triglycerides","volume":"16","author":"Marten","year":"2006","journal-title":"International Dairy Journal"},{"issue":"3","key":"10.1016\/j.xphs.2024.06.011_bib0018","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/11208580-000000000-00000","article-title":"Azithromycin 1.5% Ophthalmic Solution","volume":"72","author":"Garnock-Jones","year":"2012","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.xphs.2024.06.011_bib0019","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijpharm.2011.08.025","article-title":"Preparation of a solid-in-oil nanosuspension containing l-ascorbic acid as a novel long-term stable topical formulation","volume":"420","author":"Piao","year":"2011","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.xphs.2024.06.011_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112779","article-title":"Effect of squalane-based emulsion on polyphenols skin penetration: Ex vivo skin study","volume":"218","author":"Oliveira","year":"2022","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"key":"10.1016\/j.xphs.2024.06.011_bib0021","unstructured":"Gavaris, P., Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents. 2016: WO2017066429."},{"issue":"5-6","key":"10.1016\/j.xphs.2024.06.011_bib0022","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF02269781","article-title":"Interconversion of cyclosporin molecular form inducing peak broadening, tailing and splitting during reversed-phase liquid chromatography","volume":"38","author":"Nishikawa","year":"1994","journal-title":"Chromatographia"},{"issue":"C","key":"10.1016\/j.xphs.2024.06.011_bib0023","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0021-9673(01)87348-9","article-title":"Investigation of the mechanism of peak broadening observed in the high-performance liquid chromatographic analysis of cyclosporine","volume":"333","author":"Bowers","year":"1985","journal-title":"Journal of Chromatography A"},{"issue":"1","key":"10.1016\/j.xphs.2024.06.011_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2012.04.063","article-title":"Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models","volume":"432","author":"Abdelkader","year":"2012","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"10.1016\/j.xphs.2024.06.011_bib0025","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0272-0590(91)90246-Z","article-title":"Evaluation of seven in vitro alternatives for ocular safety testing","volume":"17","author":"Bruner","year":"1991","journal-title":"Fundamental and Applied Toxicology"},{"key":"10.1016\/j.xphs.2024.06.011_bib0026","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejpb.2019.06.008","article-title":"Topical semifluorinated alkane-based azithromycin suspension for the management of ocular infections","volume":"142","author":"Agarwal","year":"2019","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"2","key":"10.1016\/j.xphs.2024.06.011_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/JAMPS\/2017\/33924","article-title":"Quality control tests for ophthalmic pharmaceuticals: pharmacopoeial standards and specifications","volume":"14","author":"Uddin","year":"2017","journal-title":"Journal of Advances in Medical and Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.xphs.2024.06.011_bib0028","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0169-409X(95)00017-2","article-title":"Microspheres and nanoparticles used in ocular delivery systems","volume":"16","author":"Zimmer","year":"1995","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"7","key":"10.1016\/j.xphs.2024.06.011_bib0029","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/10717544.2010.483257","article-title":"Solid lipid nanoparticles for ocular drug delivery","volume":"17","author":"Seyfoddin","year":"2010","journal-title":"Drug Delivery"},{"issue":"11","key":"10.1016\/j.xphs.2024.06.011_bib0030","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/jps.2600721109","article-title":"Corneal Penetration Behavior of \u03b2-Blocking Agents II: Assessment of Barrier Contributions","volume":"72","author":"Lach","year":"1983","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.xphs.2024.06.011_bib0031","unstructured":"Amyris Inc. Penetration Study of CBD with an in-vitro Skin Model. Available at:https:\/\/aprinnova.com\/penetration-study-of-cbd-with-an-in-vitro-skin-model\/. Accessed March 13, 2023"},{"issue":"3","key":"10.1016\/j.xphs.2024.06.011_bib0032","first-page":"171","article-title":"Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations","volume":"63","author":"Loftsson","year":"2008","journal-title":"Die Pharmazie"},{"key":"10.1016\/j.xphs.2024.06.011_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104281","article-title":"Topical dexamethasone delivery to the retina: An aqueous cyclodextrin-based microsuspension","volume":"81","author":"Loftsson","year":"2023","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"12","key":"10.1016\/j.xphs.2024.06.011_bib0034","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/js9802594","article-title":"Permeability of cornea, sciera, and conjunctiva: A literature analysis for drug delivery to the eye","volume":"87","author":"Prausnitz","year":"1998","journal-title":"J. Pharma. Sci"},{"key":"10.1016\/j.xphs.2024.06.011_bib0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejps.2018.03.034","article-title":"Corneal and conjunctival drug permeability: Systematic comparison and pharmacokinetic impact in the eye","volume":"119","author":"Ramsay","year":"2018","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.xphs.2024.06.011_bib0036","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0169-409X(01)00193-4","article-title":"Transscleral drug delivery for posterior segment disease","volume":"52","author":"Geroski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.xphs.2024.06.011_bib0037","first-page":"627","article-title":"Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera","volume":"38","author":"Hamalainen","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.xphs.2024.06.011_bib0038","first-page":"570","article-title":"Surface features of the conjunctiva and cornea","volume":"24","author":"Nichols","year":"1983","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.xphs.2024.06.011_bib0039","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-3-642-38336-6_13","article-title":"Conjunctival and corneal tumors: examination techniques. eds","author":"Pe'er","year":"2014","journal-title":"Clin. Ophthalmol. Oncology"},{"issue":"8","key":"10.1016\/j.xphs.2024.06.011_bib0040","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.drudis.2019.04.002","article-title":"Ocular biopharmaceutics: impact of modeling and simulation on topical ophthalmic formulation development","volume":"24","author":"Gukasyan","year":"2019","journal-title":"Drug Discovery Today"},{"issue":"3","key":"10.1016\/j.xphs.2024.06.011_bib0041","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejps.2011.08.009","article-title":"Study of drug concentration effects on in vitro lipolysis kinetics in medium-chain triglycerides by considering oil viscosity and surface tension","volume":"44","author":"Arnold","year":"2011","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.xphs.2024.06.011_bib0042","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1143\/JPSJ.72.979","article-title":"Imbibition Driven by a Temperature Gradient","volume":"72","author":"Medina","year":"2003","journal-title":"Journal of The Physical Society of Japan"},{"key":"10.1016\/j.xphs.2024.06.011_bib0043","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.2147\/OPTH.S279051","article-title":"A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments","volume":"14","author":"Periman","year":"2020","journal-title":"Clinical ophthalmology (Auckland, N.Z.)"},{"issue":"1","key":"10.1016\/j.xphs.2024.06.011_bib0044","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1023\/A:1013671819604","article-title":"Cyclosporine A Formulation Affects Its Ocular Distribution in Rabbits","volume":"19","author":"Kuwano","year":"2002","journal-title":"Pharmaceutical research"},{"issue":"1","key":"10.1016\/j.xphs.2024.06.011_bib0045","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1248\/cpb.39.154","article-title":"In vitro transport of sodium diclofenac across rat abdominal skin: effect of selection of oleaginous component and the addition of alcohols to the vehicle","volume":"39","author":"Takahashi","year":"1991","journal-title":"Chemical & pharmaceutical bulletin"},{"issue":"8","key":"10.1016\/j.xphs.2024.06.011_bib0046","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/jps.21650","article-title":"Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability?","volume":"98","author":"Brouwers","year":"2009","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.xphs.2024.06.011_bib0047","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2006.03.015","article-title":"Use of a molecular form technique for the penetration of supersaturated solutions of salicylic acid across silicone membranes and human skin in vitro","volume":"318","author":"Leveque","year":"2006","journal-title":"International Journal of Pharmaceutics"},{"issue":"2","key":"10.1016\/j.xphs.2024.06.011_bib0048","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0378-5173(00)00346-X","article-title":"Membrane penetration enhancement of ibuprofen using supersaturation","volume":"198","author":"Iervolino","year":"2000","journal-title":"Int J Pharm"},{"issue":"20","key":"10.1016\/j.xphs.2024.06.011_bib0049","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.2174\/1381612821666150428125046","article-title":"Supersaturation as a tool for skin penetration enhancement","volume":"21","author":"Cilurzo","year":"2015","journal-title":"Current pharmaceutical design"},{"issue":"20","key":"10.1016\/j.xphs.2024.06.011_bib0050","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.2174\/1381612821666150428125046","article-title":"Supersaturation as a tool for skin penetration enhancement","volume":"21","author":"Cilurzo","year":"2015","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.xphs.2024.06.011_bib0051","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0378-5173(99)00345-2","article-title":"Effect of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate","volume":"193","author":"Raghavan","year":"2000","journal-title":"Int J Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924002302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924002302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T11:21:34Z","timestamp":1728300094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354924002302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0022354924002302"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2024.06.011","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of Ocular Penetration of Lipophilic Drugs from Lipophilic Vehicles","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2024.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}